Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2005

01-11-2005 | Report

Quantitation of HDAC1 mRNA Expression in Invasive Carcinoma of the Breast*

Authors: Zhenhuan Zhang, Hiroko Yamashita, Tatsuya Toyama, Hiroshi Sugiura, Yoshiaki Ando, Keiko Mita, Maho Hamaguchi, Yasuo Hara, Shunzo Kobayashi, Hirotaka Iwase

Published in: Breast Cancer Research and Treatment | Issue 1/2005

Login to get access
Metadata
Title
Quantitation of HDAC1 mRNA Expression in Invasive Carcinoma of the Breast*
Authors
Zhenhuan Zhang
Hiroko Yamashita
Tatsuya Toyama
Hiroshi Sugiura
Yoshiaki Ando
Keiko Mita
Maho Hamaguchi
Yasuo Hara
Shunzo Kobayashi
Hirotaka Iwase
Publication date
01-11-2005
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 1/2005
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-005-6001-1

Other articles of this Issue 1/2005

Breast Cancer Research and Treatment 1/2005 Go to the issue

Report

Nordihydroguaiaretic Acid (NDGA) Inhibits the IGF-1 and c-erbB2/HER2/neu Receptors and Suppresses Growth in Breast Cancer Cells

Report

Electrophysiological Correlates of Information Processing in Breast-Cancer Patients Treated With Adjuvant Chemotherapy

Report

Objective and Subjective Upper Body Function Six Months Following Diagnosis of Breast Cancer

Letter to the Editor

Topical Imiquimod to Treat Recurrent Breast Cancer

Report

Assessment of Breast Cancer Tumor Size Depends on Method, Histopathology and Tumor Size Itself*

Report

Angiogenic Molecule Expression is Downregulated in Effusions from Breast Cancer Patients

2024 ASCO Annual Meeting Coverage

Highlights of the Day: Breast cancer – metastatic

Breast Cancer Video

In this session, Dr. Wolff provides his key takeaways from the data presented in the metastatic breast cancer oral abstract session at ASCO 2024.

Watch now

Highlights of the Day: Gynecologic cancer

Gynecologic Cancer Video

Highlights of the Day: Breast Cancer – local/regional/adjuvant

Breast Cancer Video

Neoadjuvant dual immunotherapy improves melanoma outcomes

04-06-2024 Melanoma News

» View more highlights on the ASCO 2024 congress hub page

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits